IS1824B - Trópan-afleiður, gerð þeirra og notkun - Google Patents

Trópan-afleiður, gerð þeirra og notkun

Info

Publication number
IS1824B
IS1824B IS4825A IS4825A IS1824B IS 1824 B IS1824 B IS 1824B IS 4825 A IS4825 A IS 4825A IS 4825 A IS4825 A IS 4825A IS 1824 B IS1824 B IS 1824B
Authority
IS
Iceland
Prior art keywords
disorders
derivatives
type
monoamine neurotransmitter
uptake
Prior art date
Application number
IS4825A
Other languages
English (en)
Other versions
IS4825A (is
Inventor
Scheel-Krüger Jörgen
Moldt Peter
Wätjen Frank
Original Assignee
Neurosearch A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch A/S filed Critical Neurosearch A/S
Publication of IS4825A publication Critical patent/IS4825A/is
Publication of IS1824B publication Critical patent/IS1824B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS4825A 1996-02-22 1998-08-17 Trópan-afleiður, gerð þeirra og notkun IS1824B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK19496 1996-02-22
PCT/EP1997/000850 WO1997030997A1 (en) 1996-02-22 1997-02-21 Tropane-derivatives, their preparation and use

Publications (2)

Publication Number Publication Date
IS4825A IS4825A (is) 1998-08-17
IS1824B true IS1824B (is) 2002-10-01

Family

ID=8090830

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4825A IS1824B (is) 1996-02-22 1998-08-17 Trópan-afleiður, gerð þeirra og notkun

Country Status (31)

Country Link
US (3) US6288079B1 (is)
EP (2) EP1130020A1 (is)
JP (1) JP3238414B2 (is)
KR (1) KR100446571B1 (is)
CN (1) CN1077574C (is)
AT (1) ATE203023T1 (is)
AU (1) AU720358B2 (is)
BG (1) BG63945B1 (is)
BR (1) BR9707636A (is)
CA (1) CA2244773C (is)
CZ (1) CZ287007B6 (is)
DE (1) DE69705608T2 (is)
DK (1) DK0885220T3 (is)
EE (1) EE04751B1 (is)
ES (1) ES2159839T3 (is)
GR (1) GR3036829T3 (is)
HU (1) HU228356B1 (is)
IL (1) IL125146A (is)
IS (1) IS1824B (is)
NO (1) NO318731B1 (is)
NZ (1) NZ330886A (is)
PL (1) PL185132B1 (is)
PT (1) PT885220E (is)
RU (1) RU2167876C2 (is)
SG (1) SG99853A1 (is)
SI (1) SI0885220T1 (is)
SK (1) SK281813B6 (is)
TR (1) TR199801641T2 (is)
UA (1) UA49872C2 (is)
WO (1) WO1997030997A1 (is)
ZA (1) ZA971525B (is)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486323B1 (en) * 1998-09-30 2002-11-26 Nihon Medi-Physics Co., Ltd. Process for producing optically active tropinonemonocarboxylic acid derivative
AUPP627498A0 (en) 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
EP1397358A1 (en) * 2001-05-23 2004-03-17 Neurosearch A/S Tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
DE20203103U1 (de) * 2001-10-11 2002-07-11 Organix, Inc., Woburn, Mass. Serotonin-Wiederaufnahme-Inhibitoren
US20030114475A1 (en) * 2001-10-31 2003-06-19 Addiction Therapies, Inc. Methods for the treatment of addiction
WO2003045388A1 (en) * 2001-11-30 2003-06-05 Neurosearch A/S Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
EP1513529B1 (en) * 2002-05-30 2011-12-14 NeuroSearch A/S Triple monoamine reuptake inhibitors for the treatment of chronic pain
AU2003277827A1 (en) 2002-11-01 2004-05-25 Neurosearch A/S Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2004050690A1 (en) 2002-12-02 2004-06-17 Xenome Ltd NOVEL χ-CONOTOXIN PEPTIDES (-I)
EP2412719A1 (en) 2002-12-02 2012-02-01 Xenome Ltd Chi-conotoxin peptides
CN100372850C (zh) * 2003-02-12 2008-03-05 神经研究公司 新的8-氮杂-双环[3.2.1]辛烷衍生物和它们作为单胺神经递质再摄取抑制剂的用途
CN100551924C (zh) * 2003-02-12 2009-10-21 神经研究公司 8-氮杂-双环[3.2.1]辛烷衍生物和它们作为单胺神经递质再摄取抑制剂的用途
JP2006517568A (ja) 2003-02-12 2006-07-27 ニューロサーチ、アクティーゼルスカブ ８−アザ−ビシクロ［３．２．１］オクタン誘導体及びこれをモノアミン神経伝達物質再取り込み阻害薬として使用する方法
JP2006517567A (ja) 2003-02-12 2006-07-27 ニューロサーチ、アクティーゼルスカブ 新規８−アザ−ビシクロ［３．２．１］オクタン誘導体及びこれをモノアミン神経伝達物質再取り込み阻害薬として使用する方法
RU2344136C2 (ru) * 2003-06-24 2009-01-20 НьюроСёрч А/С Новые производные 8-аза-бицикло[3.2.1]октана и их применение в качестве ингибиторов обратного захвата моноаминовых нейротрансмиттеров
AR045141A1 (es) * 2003-07-31 2005-10-19 Neurosearch As Sales de tartrato de 2- metoximetil-3-(3,4-diclorofenil)-8-azabiciclo (3,2,1) octano. composiciones farmaceuticas que los contienen y usos de las mismas.
EP1682545B1 (en) 2003-10-03 2007-12-12 Pfizer Limited Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation
JP2007508336A (ja) * 2003-10-16 2007-04-05 ニューロサーチ、アクティーゼルスカブ モノアミン神経伝達物質再取り込みインヒビター及びアセチルコリンエステラーゼインヒビターを含む医薬組成物
NZ547880A (en) * 2003-11-18 2010-02-26 Boehringer Ingelheim Int Solid pharmaceutical preparation form
WO2005070427A1 (en) 2004-01-22 2005-08-04 Neurosearch A/S Compounds for the sustained reduction of body weight
AU2005205882A1 (en) * 2004-01-22 2005-08-04 Neurosearch A/S Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist
WO2005070428A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
DE102004004965B4 (de) * 2004-01-31 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung eines 2-(Ethoxymethyl)-tropanderivates
JP2008501656A (ja) * 2004-06-04 2008-01-24 ノイロサーチ アクティーゼルスカブ β−アミロイド（Ａβ４０及びＡβ４２）生成阻害のためのモノアミン神経伝達物質再取り込み阻害剤
US7524958B2 (en) 2004-06-18 2009-04-28 Neurosearch A/S Certain 9-aza-bicyclo[3.3.1] nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
JP2008502651A (ja) 2004-06-18 2008-01-31 ノイロサーチ アクティーゼルスカブ モノアミン神経伝達物質再取込み阻害剤としての、新規アルキル置換ピペリジン誘導体及びその使用
WO2005123728A1 (en) * 2004-06-18 2005-12-29 Neurosearch A/S Novel 9-aza-bicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
KR20070061846A (ko) 2004-09-30 2007-06-14 뉴로서치 에이/에스 신규한 크로멘-2-온 유도체 및 모노아민 신경전달물질재흡수 억제제로서의 이의 용도
AU2005288914B2 (en) * 2004-09-30 2011-05-19 Neurosearch A/S Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
DE602006007550D1 (de) 2005-02-10 2009-08-13 Neurosearch As Alkylsubstituierte homopiperazinderivate und deren verwendung als monoamin neurotransmitter wiederaufnahmeinhibitoren
WO2006106090A1 (en) * 2005-04-04 2006-10-12 Neurosearch A/S Novel substituted diazabicyclo derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20090137625A1 (en) 2005-04-08 2009-05-28 Dan Peters Novel Enantiomers and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
US8093388B2 (en) * 2005-06-28 2012-01-10 Neurosearch A/S 3-aza spiro[5,5]undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
EP1899301B1 (en) * 2005-06-28 2010-09-15 NeuroSearch A/S Novel 3-aza-spiro[5.5]undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2007000465A1 (en) * 2005-06-28 2007-01-04 Neurosearch A/S Novel 3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
EP1917264B1 (en) * 2005-06-28 2010-11-17 NeuroSearch A/S Novel 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2007006738A2 (en) * 2005-07-12 2007-01-18 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising 2 , 3-disubstituted tropanes for the treatment of disorders of sexual desire
UA95454C2 (uk) 2005-07-15 2011-08-10 Амр Текнолоджи, Інк. Арил- і гетероарилзаміщені тетрагідробензазепіни і їх застосування для блокування зворотного захоплення норепінефрину, допаміну і серотоніну
WO2007025055A2 (en) 2005-08-24 2007-03-01 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Benztropine compounds and uses thereof as dopamine uptake inhibitors
WO2007028769A1 (en) * 2005-09-05 2007-03-15 Neurosearch A/S Monoamine neurotransmitter re-uptake inhibitor for neuroprotection
WO2007028770A1 (en) * 2005-09-05 2007-03-15 Neurosearch A/S Monoamine neurotransmitter re-uptake inhibitors for neuroprotection in patients suffering from an advanced stage of a mental disease
EP1779851A1 (en) 2005-10-31 2007-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Treatment of diabetes
TW200804367A (en) 2005-11-11 2008-01-16 Neurosearch As Novel compounds
CN101379063A (zh) 2006-02-10 2009-03-04 神经研究公司 3,9-二氮杂双环[3.3.1]壬烷衍生物及其作为单胺神经递质再摄取抑制剂的用途
TW200800980A (en) 2006-02-17 2008-01-01 Neurosearch As Novel compounds
US20100234349A1 (en) 2006-09-04 2010-09-16 Olsen Gunnar M Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
BRPI0716532A2 (pt) * 2006-09-11 2013-09-24 Glaxo Group Ltd compostos azabicÍclios como inidores de reabsorÇço de monoaminas
GB0703998D0 (en) * 2007-03-01 2007-04-11 Glaxo Group Ltd Novel salt
TW200904815A (en) 2007-05-09 2009-02-01 Neurosearch As Novel compounds
US20100286195A1 (en) * 2007-09-10 2010-11-11 Neurosearch A/S Novel benzooxazol-and benzooxathiol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2009034043A1 (en) * 2007-09-10 2009-03-19 Neurosearch A/S Novel phenoxazin-3-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
EP2222303A1 (en) * 2007-11-20 2010-09-01 NeuroSearch A/S A method for treating addiction
WO2009065845A1 (en) * 2007-11-20 2009-05-28 Neurosearch A/S A method for treating over-eating disorders
AU2010247763B2 (en) 2009-05-12 2015-12-24 Albany Molecular Research, Inc. 7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof
US8815894B2 (en) 2009-05-12 2014-08-26 Bristol-Myers Squibb Company Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
US8697721B2 (en) 2009-05-15 2014-04-15 Aniona Aps Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2011032903A1 (en) 2009-09-21 2011-03-24 Neurosearch A/S Piperazinyl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2011092061A1 (en) 2010-01-29 2011-08-04 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2011117289A1 (en) 2010-03-25 2011-09-29 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neuro-transmitter re-uptake inhibitors
US8153653B2 (en) * 2010-06-22 2012-04-10 Hoffmann-La Roche Inc. Amido-tropane derivatives
WO2012000881A1 (en) 2010-07-02 2012-01-05 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2012024397A2 (en) 2010-08-17 2012-02-23 Albany Molecular Research, Inc. 2,5-methano-and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
EP2625170A1 (en) 2010-10-07 2013-08-14 Takeda Pharmaceutical Company Limited 1,4-oxazepane derivatives
HRP20190050T1 (hr) 2012-02-16 2019-03-08 Saniona A/S Farmaceutski pripravci za kombinacijsku terapiju
PE20180187A1 (es) 2015-03-03 2018-01-23 Saniona As Formulacion de combinacion de tesofensina y betabloqueante
EA026727B1 (ru) * 2015-09-10 2017-05-31 Замертон Холдингс Лимитед Соль (1r,2r,3s)-3-(3,4-дихлорфенил)-2-(этоксиметил)-8-метил-8-азабицикло[3.2.1]октана и фталевой кислоты, способ её получения, продукт способа, фармацевтические композиции для лечения и/или профилактики нарушений, связанных с ожирением, их применение и способы лечения и/или профилактики нарушений, связанных с ожирением
US20190060301A1 (en) 2016-01-15 2019-02-28 Saniona A/S Tesofensine and metoprolol for treatment of hypertension
EA028995B1 (ru) * 2016-02-25 2018-01-31 Замертон Холдингс Лимитед Соль тезофензина и оптически активных ацетиламинокислот, их применение для лечения и/или профилактики нарушений, связанных с ожирением
AU2017324406A1 (en) * 2016-09-07 2019-05-02 Saniona A/S Tesofensine compositions
DE102017210141A1 (de) 2017-06-16 2018-12-20 Henkel Ag & Co. Kgaa Portion zur Bereitstellung tensidhaltiger Flotten
MX2021008208A (es) 2019-01-07 2021-11-17 Saniona As Tesofensina para la reduccion del peso corporal para pacientes con sindrome de prader-willi.
MX2022013236A (es) 2020-04-22 2023-01-24 Saniona As Tratamiento de la obesidad hipotalamica.
TWI772928B (zh) * 2020-10-21 2022-08-01 行政院原子能委員會核能研究所 非放射性標準品β-CFT之製備方法
AU2023303077A1 (en) 2022-07-08 2025-02-06 Initiator Pharma A/S Compound for treatment of female sexual dysfunction
CN115572289A (zh) * 2022-10-24 2023-01-06 龙曦宁（上海）医药科技有限公司 一种特索芬辛的合成方法
JP2026512649A (ja) 2022-10-28 2026-04-20 イニシエーター ファーマ エー／エス 疼痛の治療用化合物
TW202440106A (zh) 2023-01-03 2024-10-16 丹麥商創始人製藥股份有限公司 用於治療勃起障礙之化合物
WO2025051846A1 (en) 2023-09-05 2025-03-13 Initiator Pharma A/S Compound for treatment of female sexual dysfunction

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281130A (en) * 1979-05-24 1981-07-28 Sterling Drug Inc. Lower-alkyl 4,6,7,8,8a-9-hexahydro-6,9-ethanothieno[3,2-f]indolizine-10-carboxylate
US5128118A (en) * 1990-08-09 1992-07-07 Research Triangle Institute Cocaine receptor binding ligands
US5496953A (en) 1990-08-09 1996-03-05 Research Triangle Institute Cocaine receptor binding ligands
US5380848A (en) * 1990-08-09 1995-01-10 Research Triangle Institute Cocaine receptor binding ligands
DK0644775T3 (da) * 1991-11-15 2000-03-06 Nat Inst Health Kokainreceptorbindende ligander
AU671163B2 (en) * 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds
AU672052B2 (en) 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds
AU672644B2 (en) * 1992-12-23 1996-10-10 Neurosearch A/S Aryl substituted heterocyclic compounds
BR9507489A (pt) * 1994-04-19 1997-08-12 Neurosearch As Derivados tropano sua preparacão e uso
GB9626611D0 (en) * 1996-12-20 1997-02-05 Unilever Plc Agglomerated silicas

Also Published As

Publication number Publication date
HU228356B1 (en) 2013-03-28
JP2000504739A (ja) 2000-04-18
US20010018444A1 (en) 2001-08-30
IS4825A (is) 1998-08-17
PL185132B1 (pl) 2003-02-28
DE69705608T2 (de) 2002-05-16
ES2159839T3 (es) 2001-10-16
US6395748B2 (en) 2002-05-28
NO318731B1 (no) 2005-05-02
EE04751B1 (et) 2006-12-15
CA2244773C (en) 2006-01-03
KR100446571B1 (ko) 2004-11-03
NO983877D0 (no) 1998-08-21
CN1077574C (zh) 2002-01-09
IL125146A (en) 2002-03-10
PL328503A1 (en) 1999-02-01
NZ330886A (en) 1999-02-25
BR9707636A (pt) 1999-07-27
BG63945B1 (bg) 2003-07-31
CA2244773A1 (en) 1997-08-28
EP0885220B1 (en) 2001-07-11
SK92998A3 (en) 1998-11-04
NO983877L (no) 1998-08-21
US20020128284A1 (en) 2002-09-12
GR3036829T3 (en) 2002-01-31
EE9800254A (et) 1999-02-15
DE69705608D1 (de) 2001-08-16
UA49872C2 (uk) 2002-10-15
CZ252098A3 (cs) 1998-11-11
CN1211982A (zh) 1999-03-24
RU2167876C2 (ru) 2001-05-27
IL125146A0 (en) 1999-01-26
ZA971525B (en) 1997-10-21
CZ287007B6 (en) 2000-08-16
PT885220E (pt) 2001-11-30
HUP9901199A2 (hu) 1999-08-30
AU1794097A (en) 1997-09-10
SK281813B6 (sk) 2001-08-06
EP1130020A1 (en) 2001-09-05
SI0885220T1 (en) 2001-12-31
HUP9901199A3 (en) 2001-02-28
HK1018957A1 (en) 2000-01-14
KR19990087127A (ko) 1999-12-15
ATE203023T1 (de) 2001-07-15
AU720358B2 (en) 2000-06-01
TR199801641T2 (xx) 1998-11-23
BG102637A (en) 1999-06-30
SG99853A1 (en) 2003-11-27
JP3238414B2 (ja) 2001-12-17
US6288079B1 (en) 2001-09-11
DK0885220T3 (da) 2001-10-15
WO1997030997A1 (en) 1997-08-28
EP0885220A1 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
IS1824B (is) Trópan-afleiður, gerð þeirra og notkun
IS6350A (is) ß2-adrenvirk viðtaka gerandefni
CY1117619T1 (el) Υδροχλωριδιο 8-χλωρο-1-μεθυλο-2,3,4,5-τετραϋδρο-1η-3βενζαζεπινης
UA105629C2 (uk) Похідні арилсульфоніл піразолін карбоксамідину як антагоністи 5-нт6
ATE446286T1 (de) Piperidin mch antagonisten und ihre verwendung in der behandlung von obesität und störungen des zentralnervensystems
FI961016A0 (fi) Bisykliset aromaattiset yhdisteet hoidollisina aineina
WO1999037623A3 (en) Sulphonamide derivatives for treatment of cns disorders
WO2008034863A3 (en) Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
DE69926254D1 (de) Verwendung von radioliganden zum screening von inhibitoren der herstellung von beta-amyloid peptiden
MXPA05003734A (es) Inhibidores de acetilcolinesterasa en el sitio de enlace dual para el tratamiento de la enfermedad de alzheimer.
MX2009005509A (es) 2-aminoquinolina como los antagonistas de los receptores 5-hidroxitriptamina 5a (5-ht5a).
DE502004011551D1 (de) 1,3,4-substituierte pyrazole als 5-ht rezeptor-antagonisten zur behandlung von psychosen und neurologischen störungen
WO2007028083A3 (en) 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
DE602007013275D1 (de) Verbindungen mit kombinierten cannabinoid-cb1-antagonismus und acetylcholinesterasehemmung
ATE452134T1 (de) Zur behandlung von auf eine modulation des dopamin-d3-rezeptors ansprechende erkrankungen geeignete 4-piperazinylpyrimidinverbindungen
MXPA05010627A (es) Derivados de 4-(2-feniloxifenil)-piperidina o 1,2,3,6-tetrahidropiridina como inhibidores de la recaptacion de serotonina.
ATE334989T1 (de) Antidepressive azaheterocyclylmethyl-derivate von 2,3-dihydro-1,4-dioxino 2,3-föchinoxalin
WO2007058805A3 (en) Compositions and methods for treating cns disorders
WO2005004867A3 (en) Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor
UA81469C2 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
TR200003569T2 (tr) 5-HT reseptörlerine karşı ilgileri olan N-benzodioksanilmetil-1-piperidil-metilamin bileşikleri.
CA2521030A1 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors